Orca Capital

What Orca Capital does

Orca Capital (睿鲸资本), operating under the alternative name Orca M&A Capital, is a privately-held strategic investment firm registered with the Asset Management Association of China under fund manager code P1062899 and headquartered in Shanghai's Xuhui District. The firm concentrates its investments in advanced manufacturing and medical devices, with an explicit thematic focus on Chinese industrial upgrading through 'import substitution' and 'labor substitution.' Its stated model combines capital deployment with operational support — integrating technology and management expertise into portfolio companies rather than acting as a purely financial sponsor.

The firm invests primarily in Chinese private enterprises with technology validated by world-leading industry players, addressing capital, technology upgrading, regulatory navigation, and market expansion needs. Its disclosed portfolio spans at least 13 companies across semiconductor equipment, autonomous driving (Motovis, GLB Auto, CoWoRobot), industrial software and simulation (Pera Global), 3D printing and additive manufacturing (DediBot), biotech and 3D cell printing (SunP BioTech), fintech (Tansun, Memect), public safety and environmental big data (Cecsys), and indoor positioning (Kunchen). Orca pursues a grid-like portfolio construction strategy intended to generate cross-portfolio synergies along industrial value chains.

The firm generates revenue through fund management fees and carried interest on successful investments, following a standard private equity/venture capital economic model. It employs a small core team of three partners (Xiao Han, Lavi Tuo/Bingjie, Steve He/Hongren), three investment managers, and two senior advisors (Daniel Adamec, Fred Ng). Deal sourcing is conducted through professional networks and referrals within China's private equity ecosystem, and investment opportunities are offered to qualified institutional investors only. The firm does not publicly disclose AUM, fund vintages, or revenue figures.

Name

Orca Capital

Legal name

睿鲸资本

Website

https://orcama.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

11–50 employees

Short description

Orca Capital (睿鲸资本) is a Shanghai-based strategic investment firm registered with China's AMAC (code P1062899) that invests capital, technology, and management support into Chinese private enterprises in advanced manufacturing and medical devices, focusing on import and labor substitution themes.

Ownership category

akta.pro rank

Product category

Private Equity and Venture Capital

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro industry

PRIMARYFSANAHAB

Captive CVC Fund (Dedicated corporate fund structure)

Financial & Insurance/Private Equity & Venture Capital/Corporate Venture Capital (CVC)

SECONDARYBPAHADAB

Corporate Finance & Capital Advisory

Business & Public Services/Professional Services (Legal, Accounting, Consulting)/Strategy & Corporate Finance Advisory

SECONDARYFSAEALAI

Institutional Capital Introduction (LP/Family Office/Endowment Matching)

Financial & Insurance/Financial Advisory, Brokerage & Intermediation/Placement Agents & Capital Raising Intermediation

Keywords

• Private equity investment
• Venture capital funds
• Strategic investment services
• Advanced manufacturing investment
• Medical device investment

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Revenue model

1. Fund Management: Revenue generated through fund management fees and carried interest from successful investments in portfolio companies

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Orca Capital is a strategic private equity and venture capital firm that invests capital integrated with technology and management expertise into advanced manufacturing and medical device companies in China. The firm focuses on industry-leading enterprises with technologies verified by world-leading firms, targeting opportunities in import substitution and labor substitution aligned with China's industrial upgrading trends. Revenue is generated through fund management fees and carried interest from successful portfolio investments.

Product overview

Orca Capital is an investment firm, not a technology product company. It does not offer software products, platforms, or SaaS solutions. The company operates as a strategic investment fund focused on advanced manufacturing and medical devices sectors in China.

Differentiator

Problem solved

Functional benefit

Products and services

• Strategic Private Equity and Venture Capital Investment Services Equity investment fund management services focused on advanced manufacturing and medical device sectors in China. The firm deploys capital integrated with technology and management expertise into industry-leading Chinese private enterprises, targeting opportunities in import substitution and labor substitution. Revenue is generated through fund management fees and carried interest from successful investments.

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• CDH Investments: Major Chinese PE firm with deep exposure to advanced manufacturing, healthcare, and industrial upgrade themes. Comparable on sector thesis but operates at a far larger AUM scale with a buyout orientation.
• Shunwei Capital: Larger China-focused venture firm with broad technology and industrial coverage. Comparable in Chinese advanced-manufacturing exposure but materially larger AUM and broader sector mandate than Orca.

Direct peers

• Matrix Partners China: Established early-to-growth-stage Chinese VC firm with a comparable thesis of backing technology-enabled industrial and consumer companies. Directly comparable as a small-team, thesis-driven generalist investor in Chinese advanced-technology plays.
• SAIF Partners: Asia-focused PE/VC firm with deep roots in Chinese technology and industrial investments. Comparable as a Chinese-domiciled investment platform serving advanced-manufacturing and growth-stage opportunities.
• Northern Light Venture Capital: China-focused early-stage VC investing across enterprise services, AI, advanced manufacturing, and frontier tech. Directly comparable in stage, sector overlap, and small-team operating model.
• Linear Venture: China-based early-stage fund focused on AI, enterprise software, robotics, and deep-tech. Comparable as a small, thesis-driven investor in Chinese advanced-technology companies with similar sector overlap (autonomous systems, industrial AI).
• Innoangel Fund: Chinese early-stage fund focused on deep-tech and industrial upgrade themes including AI, robotics, and advanced manufacturing. Comparable in stage and policy-aligned sector focus.

Regional players

• Fortune Capital: Domestic Chinese PE/VC firm with similar focus on advanced manufacturing and industrial upgrade themes. Comparable as a regionally focused Chinese sponsor, though primarily mainland-domestic in deployment.

Others

• Zero2IPO Group: China's leading PE/VC research, data, and fund-management platform. Comparable as part of the Chinese PE/VC ecosystem; functions more as an enabler and market-data provider than a direct investing peer.
• Deloitte China Corporate Finance Advisory: Advisory firm where two of Orca's partners previously worked, providing cross-border M&A and corporate finance advisory in China. Comparable as a transaction counterpart and source of cross-border deal flow rather than a direct investing competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments10 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Orca Capital